Evogene

Company Overview

Snapshot

Founded in January 2002 by Rafi Meissner and Hagai Karchi, Evogene operates with 51–200 employees. The company has raised $135.7M across 10 funding rounds from 9 investors. In October 2024, Evogene announced a collaboration with Google Cloud to develop a generative AI foundation model for novel small molecule design.

Business overview

Evogene is a computational biology company focused on advancing product discovery and development across various life sciences-based industries, including human health and agriculture. The company's core technology is its broadly applicable Computational Predictive Biology (CPB) platform, which integrates deep biological understanding with big data and artificial intelligence to computationally discover and guide the development of life sciences products based on microbes, small molecules, and genetic elements. Evogene and its subsidiaries are actively developing product pipelines for human microbiome-based therapeutics, medical cannabis, agricultural biologicals, agricultural chemicals, and castor oil production solutions.

Strategic signal

In October 2024, Evogene announced a collaboration with Google Cloud to pioneer a generative AI foundation model for novel small molecule design. This strategic partnership signals Evogene's commitment to leveraging advanced AI to accelerate drug discovery and development, potentially transforming the economics of life sciences product innovation and enhancing its competitive position in the Health Tech & Life Sciences sector.

Company Intelligence Q&A

What was a significant recent collaboration for Evogene?

In October 2024, Evogene announced a collaboration with Google Cloud to pioneer a generative AI foundation model for novel small molecule design, aiming to revolutionize life-science-based product discovery.

What was a recent development for Evogene's subsidiary, Lavie Bio?

In November 2024, Lavie Bio advanced its bio-fungicide LAV321, targeting Downy Mildew, to the pre-commercial stage following successful field trial results.

What recent grant did Lavie Bio receive?

In September 2024, Lavie Bio received a grant from the Israel Innovation Authority to advance the development of 'MicroFermentor', a technology designed to improve the economics of ag-biologicals.

What was a key operational milestone for Casterra?

In October 2024, Casterra announced the completion of its first shipment of castor seeds grown and processed in Kenya, marking a key milestone in its operational expansion plan in Africa.

When did Evogene report its Third Quarter 2025 financial results?

Evogene reported its Third Quarter 2025 financial results in November 2025, which included a conference call and webcast.